Smooth muscle contraction is regulated primarily by the reversible phosphor
ylation of myosin triggered by an increase in sarcoplasmic tree Ca2+ concen
tration ([Ca2+](i)). Contraction can, however, be modulated by other signal
transduction pathways, one of which involves the thin filament-associated
protein calponin. The hi (basic) isoform of calponin binds to actin with hi
gh affinity and is expressed specifically in smooth muscle at a molar ratio
to actin of 1 : 7. Calponin inhibits (i) the actin-activated MgATPase acti
vity of smooth muscle myosin (the cross-bridge cycling rate) via its intera
ction with actin, (ii) the movement of actin filaments over immobilized myo
sin in the in vitro motility assay, and (iii) force development or shorteni
ng velocity in permeabilized smooth muscle strips and single cells. These i
nhibitory effects of calponin can be alleviated by protein kinase C (PKC)ca
talysed phosphorylation and restored following dephosphorylation by a type
2A phosphatase. Three physiological roles of calponin can be considered bas
ed on its in vitro functional properties: (i) maintenance of relaxation at
resting [Ca2+]i, (ii) energy conservation during prolonged contractions, an
d (iii) Ca2+-independent contraction mediated by phosphorylation of calponi
n by PKC epsilon, a Ca2+-independent isoenzyme of PKC.